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DomtDNAmutationscontribute to theagingprocess, or are they innocent bystanders?Rosset al. (2013) show
that inherited mtDNA point mutations lead to a premature aging phenotype in mice and ‘‘prime’’ the maternal
lineage, interacting with subsequent somatic mutations to cause brain malformations and shorten lifespan.There is an emerging view that human
aging is not preprogrammed but, rather,
is the consequence of acquired molecular
damage that cannot be repaired, and
mitochondria appear to play a central
role (Kirkwood, 2005). Mitochondria are
present in all nucleated mammalian cells
and are the principal source of intracel-
lular energy in the form of ATP generated
by oxidative phosphorylation. Also
involved in cell calcium handling, free
radical metabolism, and the initiation of
apoptosis, it is easy to see howmitochon-
drial dysfunction might contribute to age-
related organ failure. At the same time, the
fact that mitochondria host 10% of the
cell proteome means that any age-related
disruption of cellular function is highly
likely to have secondary effects on mito-
chondria. Separating the chicken from
the egg has proven to be very challenging.
Now, Ross, Stewart, and colleagues
show that inherited mtDNA point muta-
tions cause age-related phenotypes in
mice and interact with new somatic
mtDNA mutations to cause neurodeve-
lopmental defects (Ross et al., 2013).
Mitochondria and mitochondrial pro-
teins are continuously recycled, rejuve-
nating the mitochondrial pool. Mito-
chondrial defects accumulating during
life must therefore reflect alterations in
gene expression, underpinned by genetic
or epigenetic modifications. Although
most of the 2,000 predicted mitochon-
drial proteins are synthesized within the
cytosol from nuclear gene transcripts, 13
essential components are produced by
mitochondria themselves from the 16.5
kb mitochondrial genome (mtDNA), which
also encodes 24 RNAs required for intra-
mitochondrial protein synthesis (DiMauro
et al., 2013). It is therefore of great interestthat mutations of mtDNA accumulate dur-
ing healthy aging in several mammalian
species. The introduction of a mtDNA
mutation generates a mixed population
of molecules within the cell, termed heter-
oplasmy (Figure 1A). The proportion of
mutated mtDNA can vary from cell to cell
and even over time. In healthy aged hu-
mans, the overall tissue burden of mtDNA
mutations is low (1%–2%), but in single
cells the percentage can reach very high
levels (>80%), exceeding the mutation
threshold known to cause a defect of
oxidative phosphorylation. Some of these
cells can easily be identified using a histo-
chemical stain for cytochrome c oxidase
(COX, complex IV of the respiratory chain),
and molecular analysis at the single-cell
level has shown that many COX-deficient
cells contain a single dominant species
of mutated mtDNA, which has clonally
expanded through the unequal replication
of mtDNA molecules within the mitochon-
drial pool. COX-deficient cells containing
clonally expanded mtDNA mutations
appear to be ubiquitous in postmitotic tis-
sues of aged humans, but even in the very
old they only affect a small proportion of
the cells present within an organ (<5%). It
is therefore not clear whether the
mutations actually contribute to the aging
process or are innocentminor bystanders.
Earlier work from the Larsson lab
showed that a proofread-deficient mtDNA
polymerase (pol g, encoded by POLG, or
PolgA/) causedmice to age prematurely
(Trifunovic et al., 2004), but the precise
mechanismunderpinning the agingpheno-
type has been a sourceof debate for over a
decade. In their recentNature paper, Ross,
Stewart, and colleagues show that mtDNA
mutations shorten lifespanand lead toage-
related phenotypes in mice, which includeCell Metabolism 1reduced body mass and an increase in
the heart:body weight ratio, consistent
with an age-related cardiomyopathy. Har-
nessing the exclusive maternal inheritance
pattern of mtDNA, they backcrossed fe-
male POLG-deficient mice onto a wild-
type background (Figure 1B). The aging
phenotype became more severe in subse-
quent maternal (but not paternal) descen-
dants. Introducing a further burst of so-
matic mutations into the maternal lineage
(by temporarily crossing in a POLG-defi-
cient mouse) produced a much more dra-
matic aging phenotype with COX-deficient
cells in the colon. As explained above,
these colonic cells probably harbor very
high levelsofmutantmtDNAheteroplasmy.
The overall mutation burden was sufficient
to cause reduced complex IV activity in
theheart, leading to theage-relatedcardio-
myopathy. Critically, the mice that had in-
herited low levels of mtDNA mutations
from their mother had amuchmore severe
aging phenotype than POLG-deficient
mice thathadnot inheritedanymtDNAvari-
ants. Moreover, when they looked at the
brains of the severely affected mice, they
unexpectedly found a range of different
neurodevelopmental defects.
The implications of this work are sober-
ing, given that we all appear to inherit
low-level heteroplasmic variants from
our mothers (Li et al., 2010; Payne et al.,
2013). With a limited capacity for mtDNA
repair, why don’t these mutations accu-
mulate relentlessly down the matrilineal
line, eventually leading to the mutational
meltdown of the species through Muller’s
ratchet? The new data of Ross, Stewart,
and colleagues help to clarify the com-
pensatory mechanism. Having generated
mice transmittingmtDNApoint mutations,
their first observation was a decrease in8, October 1, 2013 ª2013 Elsevier Inc. 463
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Figure 1. Inherited and Somatic Mitochondrial DNA Mutations
(A) Left: low-level heteroplasmic mtDNA mutations (different colored circles for each mutation; wild-type = blue) are passed down the female germline, but
transmission is filtered by the mtDNA genetic bottleneck. The bottleneck removes de novo mutations and maintains the transmitted mutation burden at very
low levels. Right: somatic tissues acquire new mtDNA mutations during life. The level remains low in rapidly dividing cells but can reach high levels within
individual nondividing (postmitotic) cells, including neurons, causing a defect of the mitochondrial respiratory chain (blue cell).
(B) Ross, Stewart, and colleagues tested this hypothesis by generating mice transmitting low levels of mtDNAmutations due to a proofread-deficient polymerase
Y (PolgA) and then introduced a ‘‘burst’’ of de novo somatic mutations in subsequent generations by transiently crossing in a proofread-deficient mouse (Ross
et al., 2013). The study showed that inherited mtDNA point mutations led to a premature aging phenotype in mice and primed the maternal lineage, interacting
with subsequent somatic mutations to cause brain malformations and shorten lifespan. Given emerging evidence that all humans harbor similar low-level het-
eroplasmic variants, this same mechanism could contribute to the pathogenesis of several common age-related diseases. Green circles = wild-type mtDNA, red
circles = somatically acquired mtDNA mutations, yellow circles = inherited mtDNA mutations.
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Previewsfertility. The germline therefore appears to
be exquisitely sensitive to the burden of
mtDNA mutations, limiting the transmis-
sion to subsequent generations. This
mechanism would be enhanced by the
germline genetic bottleneck, which has
recently been shown to act early during
germ cell development, and leads to the
rapid segregation of potentially delete-
rious variants while the ovary is being
formed (Freyer et al., 2012). Although
this provides an effective means of
reducing the mutational burden in the
germline over time, in the short term there
will be leakage of mtDNA variants, which
are presumably at such a low level that
they do not compromise germ cell func-
tion. This was probably not important in
early human evolution, when trauma or
infectious disease limited lifespan to
several decades. However, in an aging
population, these low-level variants may
prime the system and potentiate the ef-
fects of age-related somatic mutations464 Cell Metabolism 18, October 1, 2013 ª20of mtDNA (Figure 1). Clonally expanded
mtDNA mutations appear to be involved
in the pathogenesis of common sporadic
disorders, such as Parkinson’s disease
(Reeve et al., 2013) and Alzheimer’s dis-
ease (Krishnan et al., 2012). The findings
of Ross et al. (2013) support the notion
that our mothers may pass on a predispo-
sition to these disorders. Perhaps this ex-
plains some of the missing heritability of
common age-related human diseases;
or, as the British Daily Mail succinctly
put it, ‘‘Wrinkles? Blame mum,’’ (McDer-
mott, 2013).REFERENCES
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